La Guinée confirme un cas de la maladie à virus de Marburg, le tout premier en Afrique de l Ouest - Guinea
reliefweb.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reliefweb.int Daily Mail and Mail on Sunday newspapers.
West Africa s first-ever case of Marburg virus disease confirmed in Guinea - Guinea
reliefweb.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reliefweb.int Daily Mail and Mail on Sunday newspapers.
Nine in 10 African countries set to miss urgent COVID-19 vaccination goal
Format
Nine in 10 African countries set to miss urgent COVID-19 vaccination goal © WHO
Brazzaville – As COVID-19 cases in Africa rise for the third week running and vaccines are increasingly scarce, 47 of Africa’s 54 countries nearly 90% are set to miss the September target of vaccinating 10% of their people unless Africa receives 225 million more doses.
The new global targets were announced recently at the World Health Assembly, the world’s highest health policy-setting body, and at today’s pace only seven African countries are set to meet them.
As Africa nears 5 million COVID-19 cases, numbers are rising week-on-week and increased by nearly 20% to over 88 000 in the week ending on 6 June. The pandemic is trending upwards in 10 African countries, with four nations recording a spike in new cases of over 30% in the past seven days, compared with the previous week. 72% of all new cases were reported
Africa urgently needs 20 million second doses of COVID-19 vaccine
Format
27 May 2021
Brazzaville, 27 May 2021 – Africa needs at least 20 million doses of the Oxford-AstraZeneca vaccine in the next six weeks to get second doses to all who received a first dose within the 8 12-week interval between doses recommended by the World Health Organization (WHO).
A single dose of the Oxford-AstraZeneca vaccine gives around 70% protection for at least 12 weeks. Data on the protection from one dose after 12 weeks is limited, however COVID-19 antibodies have been found in the body up to 6 months after one dose. The full course provided with a 12-week interval gives 81% protection for an extended period.